Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes

PURPOSE: This review provides an overview of the management of chronic kidney disease (CKD) associated with type 2 diabetes (T2D), how the novel treatment class of nonsteroidal mineralocorticoid receptor antagonists (MRAs) fits within the treatment landscape, and how pharmacists can contribute to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashjian, Emily, Clarke, Megan, Pogue, Kristen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664185/
https://www.ncbi.nlm.nih.gov/pubmed/37632460
http://dx.doi.org/10.1093/ajhp/zxad192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664185/
https://www.ncbi.nlm.nih.gov/pubmed/37632460
http://dx.doi.org/10.1093/ajhp/zxad192

Ejemplares similares